ReP USP - Resultado da busca

Artigo de periodico
Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes (2022)
Pavanelli, Ana Carolina; Mangone, Flavia Rotea; Yoganathan, Piriya; Bessa, Simone Aparecida; Nonogaki, Suely; Osorio, Cynthia A. B. de Toledo; Andrade, Victor Piana de; Soares, Ibere Cauduro; Mello, Evandro Sobrosa de; Mulligan, Lois M.; Nagai, Maria Aparecida
Fonte: Breast cancer research and treatment. Unidade: FM
Assuntos: NEOPLASIAS MAMÁRIAS, ANTINEOPLÁSICOS, TERAPIA DE REPOSIÇÃO DE ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAVANELLI, Ana Carolina et al. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes. Breast cancer research and treatment, v. 192, n. 1, p. 43-52, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10549-021-06452-9. Acesso em: 19 jun. 2024.
APA
Pavanelli, A. C., Mangone, F. R., Yoganathan, P., Bessa, S. A., Nonogaki, S., Osorio, C. A. B. de T., et al. (2022). Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes. Breast cancer research and treatment, 192( 1), 43-52. doi:10.1007/s10549-021-06452-9
NLM
Pavanelli AC, Mangone FR, Yoganathan P, Bessa SA, Nonogaki S, Osorio CAB de T, Andrade VP de, Soares IC, Mello ES de, Mulligan LM, Nagai MA. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes [Internet]. Breast cancer research and treatment. 2022 ; 192( 1): 43-52.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s10549-021-06452-9
Vancouver
Pavanelli AC, Mangone FR, Yoganathan P, Bessa SA, Nonogaki S, Osorio CAB de T, Andrade VP de, Soares IC, Mello ES de, Mulligan LM, Nagai MA. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes [Internet]. Breast cancer research and treatment. 2022 ; 192( 1): 43-52.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s10549-021-06452-9
Artigo de periodico
RORγt may Influence the Microenvironment of Thyroid Cancer Predicting Favorable Prognosis (2020)
Cunha, Lucas Leite; Morari, Elaine Cristina; Nonogaki, Suely; Bufalo, Natassia Elena; Assumpção, Ligia Vera Montalli; Soares, Fernando Augusto ; Vassallo, José; Ward, Laura Sterian
Fonte: Scientific Reports. Unidade: FO
Assunto: NEOPLASIAS DA TIREOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUNHA, Lucas Leite et al. RORγt may Influence the Microenvironment of Thyroid Cancer Predicting Favorable Prognosis. Scientific Reports, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-60280-3. Acesso em: 19 jun. 2024.
APA
Cunha, L. L., Morari, E. C., Nonogaki, S., Bufalo, N. E., Assumpção, L. V. M., Soares, F. A., et al. (2020). RORγt may Influence the Microenvironment of Thyroid Cancer Predicting Favorable Prognosis. Scientific Reports. doi:10.1038/s41598-020-60280-3
NLM
Cunha LL, Morari EC, Nonogaki S, Bufalo NE, Assumpção LVM, Soares FA, Vassallo J, Ward LS. RORγt may Influence the Microenvironment of Thyroid Cancer Predicting Favorable Prognosis [Internet]. Scientific Reports. 2020 ;[citado 2024 jun. 19 ] Available from: https://doi.org/10.1038/s41598-020-60280-3
Vancouver
Cunha LL, Morari EC, Nonogaki S, Bufalo NE, Assumpção LVM, Soares FA, Vassallo J, Ward LS. RORγt may Influence the Microenvironment of Thyroid Cancer Predicting Favorable Prognosis [Internet]. Scientific Reports. 2020 ;[citado 2024 jun. 19 ] Available from: https://doi.org/10.1038/s41598-020-60280-3
Artigo de periodico
Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC) (2018)
Alcantara Filho, Paulo R. de; Mangone, Flavia R; Pavanelli, Ana C; Garcia, Simone A. de Bessa; Nonogaki, Suely; Andrade, Victor P. De; Nagai, Maria A.
Fonte: Breast cancer management. Unidade: FM
Assuntos: NEOPLASIAS MAMÁRIAS, EXPRESSÃO GÊNICA, IMUNOHISTOQUÍMICA, PROTEÍNAS DO TECIDO CONJUNTIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALCANTARA FILHO, Paulo R. de et al. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC). Breast cancer management, v. 7, n. 2, 2018Tradução . . Disponível em: https://doi.org/10.2217/bmt-2017-0019. Acesso em: 19 jun. 2024.
APA
Alcantara Filho, P. R. de, Mangone, F. R., Pavanelli, A. C., Garcia, S. A. de B., Nonogaki, S., Andrade, V. P. D., & Nagai, M. A. (2018). Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC). Breast cancer management, 7( 2). doi:10.2217/bmt-2017-0019
NLM
Alcantara Filho PR de, Mangone FR, Pavanelli AC, Garcia SA de B, Nonogaki S, Andrade VPD, Nagai MA. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC) [Internet]. Breast cancer management. 2018 ; 7( 2):[citado 2024 jun. 19 ] Available from: https://doi.org/10.2217/bmt-2017-0019
Vancouver
Alcantara Filho PR de, Mangone FR, Pavanelli AC, Garcia SA de B, Nonogaki S, Andrade VPD, Nagai MA. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC) [Internet]. Breast cancer management. 2018 ; 7( 2):[citado 2024 jun. 19 ] Available from: https://doi.org/10.2217/bmt-2017-0019
Artigo de periodico
Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes A large diagnostic study using tissue microarray: A large diagnostic study using tissue microarray (2018)
Logullo, Angela Flávia; Pasini, Fatima Solange; Nonogaki, Suely; Rocha, Rafael Malagoli; Soares, Fernando Augusto; Brentani, Maria Mitzi
Fonte: Molecular and Clinical Oncology. Unidade: FO
Assuntos: CLAUDIN, CARCINONA MAMÁRIA, ANÁLICE DO MICROARRAY DO TECIDO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOGULLO, Angela Flávia et al. Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes A large diagnostic study using tissue microarray: A large diagnostic study using tissue microarray. Molecular and Clinical Oncology, v. 9, p. 377-388, 2018Tradução . . Disponível em: https://doi.org/10.3892/mco.2018.1685. Acesso em: 19 jun. 2024.
APA
Logullo, A. F., Pasini, F. S., Nonogaki, S., Rocha, R. M., Soares, F. A., & Brentani, M. M. (2018). Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes A large diagnostic study using tissue microarray: A large diagnostic study using tissue microarray. Molecular and Clinical Oncology, 9, 377-388. doi:10.3892/mco.2018.1685
NLM
Logullo AF, Pasini FS, Nonogaki S, Rocha RM, Soares FA, Brentani MM. Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes A large diagnostic study using tissue microarray: A large diagnostic study using tissue microarray [Internet]. Molecular and Clinical Oncology. 2018 ; 9 377-388.[citado 2024 jun. 19 ] Available from: https://doi.org/10.3892/mco.2018.1685
Vancouver
Logullo AF, Pasini FS, Nonogaki S, Rocha RM, Soares FA, Brentani MM. Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes A large diagnostic study using tissue microarray: A large diagnostic study using tissue microarray [Internet]. Molecular and Clinical Oncology. 2018 ; 9 377-388.[citado 2024 jun. 19 ] Available from: https://doi.org/10.3892/mco.2018.1685
Artigo de periodico
Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes: A large diagnostic study using tissue microarray: a large diagnostic study using tissue microarray (2018)
Logullo, Angela Flávia; Pasini, Fatima Solange; Nonogaki, Suely; Rocha, Rafael Malagoli; Soares, Fernando Augusto; Brentani, Maria Mitzi
Fonte: Molecular and Clinical Oncology. Unidades: FO, FM
Assuntos: CARCINOMA, IMUNOHISTOQUÍMICA, ARRANJO FÍSICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOGULLO, Angela Flávia et al. Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes: A large diagnostic study using tissue microarray: a large diagnostic study using tissue microarray. Molecular and Clinical Oncology, 2018Tradução . . Disponível em: https://doi.org/10.3892/mco.2018.1685. Acesso em: 19 jun. 2024.
APA
Logullo, A. F., Pasini, F. S., Nonogaki, S., Rocha, R. M., Soares, F. A., & Brentani, M. M. (2018). Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes: A large diagnostic study using tissue microarray: a large diagnostic study using tissue microarray. Molecular and Clinical Oncology. doi:10.3892/mco.2018.1685
NLM
Logullo AF, Pasini FS, Nonogaki S, Rocha RM, Soares FA, Brentani MM. Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes: A large diagnostic study using tissue microarray: a large diagnostic study using tissue microarray [Internet]. Molecular and Clinical Oncology. 2018 ;[citado 2024 jun. 19 ] Available from: https://doi.org/10.3892/mco.2018.1685
Vancouver
Logullo AF, Pasini FS, Nonogaki S, Rocha RM, Soares FA, Brentani MM. Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes: A large diagnostic study using tissue microarray: a large diagnostic study using tissue microarray [Internet]. Molecular and Clinical Oncology. 2018 ;[citado 2024 jun. 19 ] Available from: https://doi.org/10.3892/mco.2018.1685
Artigo de periodico
HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner (2018)
Rabachini, Tatiana; Boccardo, Enrique ; Andrade, Rubiana; Perez, Katia Regina; Nonogaki, Suely; Cuccovia, Iolanda Midea ; Villa, Luisa Lina
Fonte: BMC Cancer. Unidades: ICB, IQ, FM
Assuntos: HPV, FOSFOLIPASES, MICROBIOLOGIA, PAPILLOMAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RABACHINI, Tatiana et al. HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner. BMC Cancer, v. 18, p. 1-8 art. 485, 2018Tradução . . Disponível em: https://doi.org/10.1186/s12885-018-4392-8. Acesso em: 19 jun. 2024.
APA
Rabachini, T., Boccardo, E., Andrade, R., Perez, K. R., Nonogaki, S., Cuccovia, I. M., & Villa, L. L. (2018). HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner. BMC Cancer, 18, 1-8 art. 485. doi:10.1186/s12885-018-4392-8
NLM
Rabachini T, Boccardo E, Andrade R, Perez KR, Nonogaki S, Cuccovia IM, Villa LL. HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner [Internet]. BMC Cancer. 2018 ; 18 1-8 art. 485.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1186/s12885-018-4392-8
Vancouver
Rabachini T, Boccardo E, Andrade R, Perez KR, Nonogaki S, Cuccovia IM, Villa LL. HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner [Internet]. BMC Cancer. 2018 ; 18 1-8 art. 485.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1186/s12885-018-4392-8
Artigo de periodico
Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer (2018)
Barros, Francisco Bárbara Abreu; Assao, Agnes; Garcia, Natália Galvão; Nonogaki, Suely; Carvalho, André Lopes; Soares, Fernando Augusto; Kowalski, Luiz Paulo; Oliveira, Denise Tostes
Fonte: BMC Cancer. Unidade: FOB
Assuntos: CARCINOMA DE CÉLULAS ESCAMOSAS, GLICOPROTEÍNAS DA MEMBRANA, ACTINAS, FILAMENTOS CITOPLASMÁTICOS, BIOMARCADORES, NEOPLASIAS BUCAIS, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARROS, Francisco Bárbara Abreu et al. Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer. BMC Cancer, v. 18, n. ja 2018, p. 8, 2018Tradução . . Disponível em: http://lattes.cnpq.br/0483990125574816. Acesso em: 19 jun. 2024.
APA
Barros, F. B. A., Assao, A., Garcia, N. G., Nonogaki, S., Carvalho, A. L., Soares, F. A., et al. (2018). Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer. BMC Cancer, 18( ja 2018), 8. doi:10.1186/s12885-017-3914-0
NLM
Barros FBA, Assao A, Garcia NG, Nonogaki S, Carvalho AL, Soares FA, Kowalski LP, Oliveira DT. Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer [Internet]. BMC Cancer. 2018 ; 18( ja 2018): 8.[citado 2024 jun. 19 ] Available from: http://lattes.cnpq.br/0483990125574816
Vancouver
Barros FBA, Assao A, Garcia NG, Nonogaki S, Carvalho AL, Soares FA, Kowalski LP, Oliveira DT. Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer [Internet]. BMC Cancer. 2018 ; 18( ja 2018): 8.[citado 2024 jun. 19 ] Available from: http://lattes.cnpq.br/0483990125574816
Artigo de periodico
Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer (2017)
Rêgo, Juliana Florinda de M.; Medeiros, Raphael Salles Scortegagna de; Braghiroli, Maria Ignez; Galvão, Breno; Bezerra Neto, João Evangelista; Munhoz, Rodrigo Ramella; Guerra, Juliana; Nonogaki, Suely; Kimura, Lidia; Pfiffer, Tulio Eduardo; Castro Jr, Gilberto de; Hoff, Paulo Marcelo; Rocha Filho, Duilio; Costa, Frederico Perego; Riechelmann, Rachel P.
Fonte: ecancermedicalscience. Unidade: FM
Assuntos: BIOMARCADORES, QUIMIOTERAPIA, NEOPLASIA ENDÓCRINA MÚLTIPLA, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RÊGO, Juliana Florinda de M. et al. Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer. ecancermedicalscience, v. 11, 2017Tradução . . Disponível em: https://doi.org/10.3332/ecancer.2017.767. Acesso em: 19 jun. 2024.
APA
Rêgo, J. F. de M., Medeiros, R. S. S. de, Braghiroli, M. I., Galvão, B., Bezerra Neto, J. E., Munhoz, R. R., et al. (2017). Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer. ecancermedicalscience, 11. doi:10.3332/ecancer.2017.767
NLM
Rêgo JF de M, Medeiros RSS de, Braghiroli MI, Galvão B, Bezerra Neto JE, Munhoz RR, Guerra J, Nonogaki S, Kimura L, Pfiffer TE, Castro Jr G de, Hoff PM, Rocha Filho D, Costa FP, Riechelmann RP. Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer [Internet]. ecancermedicalscience. 2017 ; 11[citado 2024 jun. 19 ] Available from: https://doi.org/10.3332/ecancer.2017.767
Vancouver
Rêgo JF de M, Medeiros RSS de, Braghiroli MI, Galvão B, Bezerra Neto JE, Munhoz RR, Guerra J, Nonogaki S, Kimura L, Pfiffer TE, Castro Jr G de, Hoff PM, Rocha Filho D, Costa FP, Riechelmann RP. Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer [Internet]. ecancermedicalscience. 2017 ; 11[citado 2024 jun. 19 ] Available from: https://doi.org/10.3332/ecancer.2017.767
Artigo de periodico
Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer (2017)
Assao, Agnes; Nonogaki, Suely; Lauris, José Roberto Pereira; Carvalho, André Lopes; Pinto, Clóvis Antônio Lopes; Soares, Fernando Augusto; Kowalski, Luiz Paulo; Oliveira, Denise Tostes
Fonte: Clinical Oral Investigations. Unidades: FOB, FO
Assuntos: NEOPLASIAS, LÁBIO, ODONTOLOGIA, PATOLOGIA BUCAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASSAO, Agnes et al. Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer. Clinical Oral Investigations, v. 21, n. 5, p. 1647-1657, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00784-016-1956-3. Acesso em: 19 jun. 2024.
APA
Assao, A., Nonogaki, S., Lauris, J. R. P., Carvalho, A. L., Pinto, C. A. L., Soares, F. A., et al. (2017). Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer. Clinical Oral Investigations, 21( 5), 1647-1657. doi:10.1007/s00784-016-1956-3
NLM
Assao A, Nonogaki S, Lauris JRP, Carvalho AL, Pinto CAL, Soares FA, Kowalski LP, Oliveira DT. Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer [Internet]. Clinical Oral Investigations. 2017 ; 21( 5): 1647-1657.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s00784-016-1956-3
Vancouver
Assao A, Nonogaki S, Lauris JRP, Carvalho AL, Pinto CAL, Soares FA, Kowalski LP, Oliveira DT. Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer [Internet]. Clinical Oral Investigations. 2017 ; 21( 5): 1647-1657.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s00784-016-1956-3
Artigo de periodico
Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer (2016)
Assao, Agnes; Nonogaki, Suely; Lauris, José Roberto Pereira; Carvalho, André Lopes; Pinto, Clóvis Antônio Lopes; Soares, Fernando Augusto; Kowalski, Luiz Paulo; Oliveira, Denise Tostes
Fonte: Clinical Oral Investigations. Unidade: FO
Assunto: NEOPLASIAS BUCAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASSAO, Agnes et al. Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer. Clinical Oral Investigations, v. 20, n. 7, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00784-016-1956-3. Acesso em: 19 jun. 2024.
APA
Assao, A., Nonogaki, S., Lauris, J. R. P., Carvalho, A. L., Pinto, C. A. L., Soares, F. A., et al. (2016). Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer. Clinical Oral Investigations, 20( 7). doi:10.1007/s00784-016-1956-3
NLM
Assao A, Nonogaki S, Lauris JRP, Carvalho AL, Pinto CAL, Soares FA, Kowalski LP, Oliveira DT. Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer [Internet]. Clinical Oral Investigations. 2016 ; 20( 7):[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s00784-016-1956-3
Vancouver
Assao A, Nonogaki S, Lauris JRP, Carvalho AL, Pinto CAL, Soares FA, Kowalski LP, Oliveira DT. Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer [Internet]. Clinical Oral Investigations. 2016 ; 20( 7):[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s00784-016-1956-3
Artigo de periodico
M2 macrophages and inflammatory cells in oral lesions of chronic paracoccidioidomycosis (2016)
Carli, Marina Lara de; Miyazawa, Marta; Nonogaki, Suely; Shirata, Neuza Kasumi; Oliveira, Denise Tostes; Pereira, Alessandro Antônio Costa; Hanemann, João Adolfo Costa
Fonte: Journal of Oral Pathology & Medicine. Unidade: FOB
Assuntos: INFLAMAÇÃO, MACRÓFAGOS, PARACOCCIDIOIDES, PARACOCCIDIOIDOMICOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLI, Marina Lara de et al. M2 macrophages and inflammatory cells in oral lesions of chronic paracoccidioidomycosis. Journal of Oral Pathology & Medicine, v. 45, n. 2, p. 141-147, 2016Tradução . . Disponível em: https://doi.org/10.1111/jop.12333. Acesso em: 19 jun. 2024.
APA
Carli, M. L. de, Miyazawa, M., Nonogaki, S., Shirata, N. K., Oliveira, D. T., Pereira, A. A. C., & Hanemann, J. A. C. (2016). M2 macrophages and inflammatory cells in oral lesions of chronic paracoccidioidomycosis. Journal of Oral Pathology & Medicine, 45( 2), 141-147. doi:10.1111/jop.12333
NLM
Carli ML de, Miyazawa M, Nonogaki S, Shirata NK, Oliveira DT, Pereira AAC, Hanemann JAC. M2 macrophages and inflammatory cells in oral lesions of chronic paracoccidioidomycosis [Internet]. Journal of Oral Pathology & Medicine. 2016 ; 45( 2): 141-147.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1111/jop.12333
Vancouver
Carli ML de, Miyazawa M, Nonogaki S, Shirata NK, Oliveira DT, Pereira AAC, Hanemann JAC. M2 macrophages and inflammatory cells in oral lesions of chronic paracoccidioidomycosis [Internet]. Journal of Oral Pathology & Medicine. 2016 ; 45( 2): 141-147.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1111/jop.12333
Artigo de periodico
Correlation of beta-2 adrenergic receptor expression in tumor-free surgical margin and at the invasive front of oral squamous cell carcinoma (2016)
Oliveira, Denise Tostes; Bravo-Calderón, Diego Mauricio; Lauand, Gustavo Amaral; Assao, Agnes; Suárez-Peñaranda, José-Manuel; Pérez-Sayáns, Mario; García-García, Abel; Marana, Aparecido Nilceu; Nonogaki, Suely; Lauris, José Roberto Pereira; Kowalski, Luiz Paulo
Fonte: Journal of Oncology. Unidade: FOB
Assuntos: RECEPTORES ADRENÉRGICOS, CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS BUCAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Denise Tostes et al. Correlation of beta-2 adrenergic receptor expression in tumor-free surgical margin and at the invasive front of oral squamous cell carcinoma. Journal of Oncology, v. 2016, 2016Tradução . . Disponível em: https://doi.org/10.1155/2016/3531274. Acesso em: 19 jun. 2024.
APA
Oliveira, D. T., Bravo-Calderón, D. M., Lauand, G. A., Assao, A., Suárez-Peñaranda, J. -M., Pérez-Sayáns, M., et al. (2016). Correlation of beta-2 adrenergic receptor expression in tumor-free surgical margin and at the invasive front of oral squamous cell carcinoma. Journal of Oncology, 2016. doi:10.1155/2016/3531274
NLM
Oliveira DT, Bravo-Calderón DM, Lauand GA, Assao A, Suárez-Peñaranda J-M, Pérez-Sayáns M, García-García A, Marana AN, Nonogaki S, Lauris JRP, Kowalski LP. Correlation of beta-2 adrenergic receptor expression in tumor-free surgical margin and at the invasive front of oral squamous cell carcinoma [Internet]. Journal of Oncology. 2016 ; 2016[citado 2024 jun. 19 ] Available from: https://doi.org/10.1155/2016/3531274
Vancouver
Oliveira DT, Bravo-Calderón DM, Lauand GA, Assao A, Suárez-Peñaranda J-M, Pérez-Sayáns M, García-García A, Marana AN, Nonogaki S, Lauris JRP, Kowalski LP. Correlation of beta-2 adrenergic receptor expression in tumor-free surgical margin and at the invasive front of oral squamous cell carcinoma [Internet]. Journal of Oncology. 2016 ; 2016[citado 2024 jun. 19 ] Available from: https://doi.org/10.1155/2016/3531274
Trabalho de evento-resumo
Expressão imunohistoquímica da podoplanina e moesina em carcinomas espinocelulares de lábio (2015)
Yoshino, Paula Midori; Assao, Agnes; Soares, Fernando Augusto; Nonogaki, Suely; Pinto, Clóvis Antônio Lopes; Lauris, José Roberto Pereira; Carvalho, André Lopes; Oliveira, Denise Tostes
Fonte: Resumos. Nome do evento: Simpósio Internacional de Iniciação Científica da Universidade de São Paulo - SIICUSP. Unidades: FO, FOB
Assuntos: IMUNOHISTOQUÍMICA, CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS LABIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOSHINO, Paula Midori et al. Expressão imunohistoquímica da podoplanina e moesina em carcinomas espinocelulares de lábio. 2015, Anais.. São Paulo: Universidade de São Paulo, 2015. . Acesso em: 19 jun. 2024.
APA
Yoshino, P. M., Assao, A., Soares, F. A., Nonogaki, S., Pinto, C. A. L., Lauris, J. R. P., et al. (2015). Expressão imunohistoquímica da podoplanina e moesina em carcinomas espinocelulares de lábio. In Resumos. São Paulo: Universidade de São Paulo.
NLM
Yoshino PM, Assao A, Soares FA, Nonogaki S, Pinto CAL, Lauris JRP, Carvalho AL, Oliveira DT. Expressão imunohistoquímica da podoplanina e moesina em carcinomas espinocelulares de lábio. Resumos. 2015 ;[citado 2024 jun. 19 ]
Vancouver
Yoshino PM, Assao A, Soares FA, Nonogaki S, Pinto CAL, Lauris JRP, Carvalho AL, Oliveira DT. Expressão imunohistoquímica da podoplanina e moesina em carcinomas espinocelulares de lábio. Resumos. 2015 ;[citado 2024 jun. 19 ]
Artigo de periodico
MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases (2015)
Mundim, Fiorita Gonzales Lopes; Pasini, Fatima Solange; Brentani, Maria Mitzi; Soares, Fernando Augusto; Nonogaki, Suely; Waitzberg, Angela Flayia Logullo
Fonte: Molecular and clinical oncology. Unidade: FM
Assuntos: CARCINOMA, METÁSTASE NEOPLÁSICA, CÉLULAS ESTROMAIS, CÉLULAS EPITELIAIS, ONCOGENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNDIM, Fiorita Gonzales Lopes et al. MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases. Molecular and clinical oncology, v. 3, n. 3, p. 506-514, 2015Tradução . . Disponível em: https://doi.org/10.3892/mco.2015.526. Acesso em: 19 jun. 2024.
APA
Mundim, F. G. L., Pasini, F. S., Brentani, M. M., Soares, F. A., Nonogaki, S., & Waitzberg, A. F. L. (2015). MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases. Molecular and clinical oncology, 3( 3), 506-514. doi:10.3892/mco.2015.526
NLM
Mundim FGL, Pasini FS, Brentani MM, Soares FA, Nonogaki S, Waitzberg AFL. MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases [Internet]. Molecular and clinical oncology. 2015 ; 3( 3): 506-514.[citado 2024 jun. 19 ] Available from: https://doi.org/10.3892/mco.2015.526
Vancouver
Mundim FGL, Pasini FS, Brentani MM, Soares FA, Nonogaki S, Waitzberg AFL. MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases [Internet]. Molecular and clinical oncology. 2015 ; 3( 3): 506-514.[citado 2024 jun. 19 ] Available from: https://doi.org/10.3892/mco.2015.526
Trabalho de evento-resumo periodico
High-grade extrapulmonary neuroendocrine carcinomas and small cell lung cancer: Different entities, same treatment (2015)
Rego, Juliana Florinda De Mendonga; Medeiros, Raphael Salles S.; Braghiroli, Maria Ignez Freitas Melro; Galvao, Breno; Bezerra Neto, Joao Evangelista; Munhoz, Rodrigo Ramella; Guerra, Juliana Mariotti; Kimura, Lidia; Nonogaki, Suely; Pfiffer, Tulio Eduardo Flesch; Castro, Gilberto; Hoff, Paulo Marcelo; Rocha Filho, Duilio; Costa, Frederico; Riechelmann, Rachel Pimenta
Fonte: Journal of Clinical Oncology. Nome do evento: ASCO Annual Meeting. Unidade: FM
Assuntos: NEOPLASIAS PULMONARES (TERAPIA), BIOMARCADORES, CARCINOMA NEUROENDÓCRINO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REGO, Juliana Florinda De Mendonga et al. High-grade extrapulmonary neuroendocrine carcinomas and small cell lung cancer: Different entities, same treatment. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e15176?sid=d383ce87-0bfa-4a25-b2d7-df3d450bdf33. Acesso em: 19 jun. 2024. , 2015
APA
Rego, J. F. D. M., Medeiros, R. S. S., Braghiroli, M. I. F. M., Galvao, B., Bezerra Neto, J. E., Munhoz, R. R., et al. (2015). High-grade extrapulmonary neuroendocrine carcinomas and small cell lung cancer: Different entities, same treatment. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e15176?sid=d383ce87-0bfa-4a25-b2d7-df3d450bdf33
NLM
Rego JFDM, Medeiros RSS, Braghiroli MIFM, Galvao B, Bezerra Neto JE, Munhoz RR, Guerra JM, Kimura L, Nonogaki S, Pfiffer TEF, Castro G, Hoff PM, Rocha Filho D, Costa F, Riechelmann RP. High-grade extrapulmonary neuroendocrine carcinomas and small cell lung cancer: Different entities, same treatment [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2024 jun. 19 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e15176?sid=d383ce87-0bfa-4a25-b2d7-df3d450bdf33
Vancouver
Rego JFDM, Medeiros RSS, Braghiroli MIFM, Galvao B, Bezerra Neto JE, Munhoz RR, Guerra JM, Kimura L, Nonogaki S, Pfiffer TEF, Castro G, Hoff PM, Rocha Filho D, Costa F, Riechelmann RP. High-grade extrapulmonary neuroendocrine carcinomas and small cell lung cancer: Different entities, same treatment [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2024 jun. 19 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e15176?sid=d383ce87-0bfa-4a25-b2d7-df3d450bdf33
Artigo de periodico
Podoplanin and ezrin expression in tumoral invasion process of the ameloblastomas (2015)
Assao, Agnes; Costa, Yara Francine; Tjioe, Kellen Cristine; Soares, Fernando Augusto; Nonogaki, Suely; Lauris, José Roberto Pereira; Oliveira, Denise Tostes
Fonte: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology. Unidade: FOB
Assuntos: AMELOBLASTOMA, TUMORES ODONTOGÊNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASSAO, Agnes et al. Podoplanin and ezrin expression in tumoral invasion process of the ameloblastomas. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, v. 119, n. 3, p. e179-e180, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.oooo.2014.07.344. Acesso em: 19 jun. 2024.
APA
Assao, A., Costa, Y. F., Tjioe, K. C., Soares, F. A., Nonogaki, S., Lauris, J. R. P., & Oliveira, D. T. (2015). Podoplanin and ezrin expression in tumoral invasion process of the ameloblastomas. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, 119( 3), e179-e180. doi:10.1016/j.oooo.2014.07.344
NLM
Assao A, Costa YF, Tjioe KC, Soares FA, Nonogaki S, Lauris JRP, Oliveira DT. Podoplanin and ezrin expression in tumoral invasion process of the ameloblastomas [Internet]. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology. 2015 ; 119( 3): e179-e180.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1016/j.oooo.2014.07.344
Vancouver
Assao A, Costa YF, Tjioe KC, Soares FA, Nonogaki S, Lauris JRP, Oliveira DT. Podoplanin and ezrin expression in tumoral invasion process of the ameloblastomas [Internet]. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology. 2015 ; 119( 3): e179-e180.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1016/j.oooo.2014.07.344
Artigo de periodico
Ezrin and podoplanin expressions are associated in invasion front of lip cancer (2015)
Assao, Agnes; Garcia, Alexandre Simões; Tjioe, Kellen Cristine; Soares, Cléverson Teixeira; Nonogaki, Suely; Lauris, José Roberto Pereira; Oliveira, Denise Tostes
Fonte: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology. Unidade: FOB
Assuntos: CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS BUCAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASSAO, Agnes et al. Ezrin and podoplanin expressions are associated in invasion front of lip cancer. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, v. 119, n. 3, p. e180, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.oooo.2014.07.345. Acesso em: 19 jun. 2024.
APA
Assao, A., Garcia, A. S., Tjioe, K. C., Soares, C. T., Nonogaki, S., Lauris, J. R. P., & Oliveira, D. T. (2015). Ezrin and podoplanin expressions are associated in invasion front of lip cancer. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, 119( 3), e180. doi:10.1016/j.oooo.2014.07.345
NLM
Assao A, Garcia AS, Tjioe KC, Soares CT, Nonogaki S, Lauris JRP, Oliveira DT. Ezrin and podoplanin expressions are associated in invasion front of lip cancer [Internet]. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology. 2015 ; 119( 3): e180.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1016/j.oooo.2014.07.345
Vancouver
Assao A, Garcia AS, Tjioe KC, Soares CT, Nonogaki S, Lauris JRP, Oliveira DT. Ezrin and podoplanin expressions are associated in invasion front of lip cancer [Internet]. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology. 2015 ; 119( 3): e180.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1016/j.oooo.2014.07.345
Trabalho de evento-resumo periodico
Metastatic lymph node fibroblasts maintain similar profile of stromal biomarkers registered in primary breast carcinomas (2015)
Mundim, Fiorita G. L.; Pasini, Fatima S.; Nonogaki, Suely; Soares, Fernando A.; Brentani, M. Mitzi; Logullo, Angela F.
Fonte: Cancer Research. Nome do evento: Annual CTRC-AACR San Antonio Breast Cancer Symposium. Unidades: FM, FO
Assuntos: BIOMARCADORES, NEOPLASIAS MAMÁRIAS (GENÉTICA), FIBROBLASTOS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNDIM, Fiorita G. L. et al. Metastatic lymph node fibroblasts maintain similar profile of stromal biomarkers registered in primary breast carcinomas. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS14-P4-04-24. Acesso em: 19 jun. 2024. , 2015
APA
Mundim, F. G. L., Pasini, F. S., Nonogaki, S., Soares, F. A., Brentani, M. M., & Logullo, A. F. (2015). Metastatic lymph node fibroblasts maintain similar profile of stromal biomarkers registered in primary breast carcinomas. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS14-P4-04-24
NLM
Mundim FGL, Pasini FS, Nonogaki S, Soares FA, Brentani MM, Logullo AF. Metastatic lymph node fibroblasts maintain similar profile of stromal biomarkers registered in primary breast carcinomas [Internet]. Cancer Research. 2015 ; 75[citado 2024 jun. 19 ] Available from: https://doi.org/10.1158/1538-7445.SABCS14-P4-04-24
Vancouver
Mundim FGL, Pasini FS, Nonogaki S, Soares FA, Brentani MM, Logullo AF. Metastatic lymph node fibroblasts maintain similar profile of stromal biomarkers registered in primary breast carcinomas [Internet]. Cancer Research. 2015 ; 75[citado 2024 jun. 19 ] Available from: https://doi.org/10.1158/1538-7445.SABCS14-P4-04-24
Trabalho de evento-resumo periodico
Evaluation of predictive biomarkers of response and prognosis in patients with high-grade extrapulmonary neuroendocrine carcinomas treated with platin-based chemotherapy (2015)
Rego, Juliana Florinda De Mendonga; Medeiros, Raphael Salles S.; Braghiroli, Maria Ignez Freitas Melro; Galvao, Breno; Bezerra Neto, Joao Evangelista; Munhoz, Rodrigo Ramella; Guerra, Juliana Mariotti; Kimura, Lidia; Nonogaki, Suely; Pfiffer, Tulio Eduardo Flesch; Hoff, Paulo Marcelo; Rocha Filho, Duilio; Costa, Frederico; Riechelmann, Rachel Pimenta
Fonte: Journal of Clinical Oncology. Nome do evento: ASCO Annual Meeting. Unidade: FM
Assuntos: PROGNÓSTICO, BIOMARCADORES, CARCINOMA NEUROENDÓCRINO (QUIMIOTERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REGO, Juliana Florinda De Mendonga et al. Evaluation of predictive biomarkers of response and prognosis in patients with high-grade extrapulmonary neuroendocrine carcinomas treated with platin-based chemotherapy. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e15183?sid=3a7d1fff-5c77-4444-a533-5a64108ca202. Acesso em: 19 jun. 2024. , 2015
APA
Rego, J. F. D. M., Medeiros, R. S. S., Braghiroli, M. I. F. M., Galvao, B., Bezerra Neto, J. E., Munhoz, R. R., et al. (2015). Evaluation of predictive biomarkers of response and prognosis in patients with high-grade extrapulmonary neuroendocrine carcinomas treated with platin-based chemotherapy. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e15183?sid=3a7d1fff-5c77-4444-a533-5a64108ca202
NLM
Rego JFDM, Medeiros RSS, Braghiroli MIFM, Galvao B, Bezerra Neto JE, Munhoz RR, Guerra JM, Kimura L, Nonogaki S, Pfiffer TEF, Hoff PM, Rocha Filho D, Costa F, Riechelmann RP. Evaluation of predictive biomarkers of response and prognosis in patients with high-grade extrapulmonary neuroendocrine carcinomas treated with platin-based chemotherapy [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2024 jun. 19 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e15183?sid=3a7d1fff-5c77-4444-a533-5a64108ca202
Vancouver
Rego JFDM, Medeiros RSS, Braghiroli MIFM, Galvao B, Bezerra Neto JE, Munhoz RR, Guerra JM, Kimura L, Nonogaki S, Pfiffer TEF, Hoff PM, Rocha Filho D, Costa F, Riechelmann RP. Evaluation of predictive biomarkers of response and prognosis in patients with high-grade extrapulmonary neuroendocrine carcinomas treated with platin-based chemotherapy [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2024 jun. 19 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e15183?sid=3a7d1fff-5c77-4444-a533-5a64108ca202
Trabalho de evento-resumo periodico
Is the podoplanin associated with ezrin part of the process of invasion by ameloblastomas? (2014)
Costa, Yara Francine; Tjioe, Kellen Cristine; Nonogaki, Suely; Soares, Fernando Augusto; Lauris, José Roberto Pereira; Oliveira, Denise Tostes
Fonte: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. Nome do evento: Brazilian Congress of Oral Medicine and Oral Pathology. Unidade: FOB
Assuntos: AMELOBLASTOMA, TUMORES ODONTOGÊNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Yara Francine et al. Is the podoplanin associated with ezrin part of the process of invasion by ameloblastomas?. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. Nova York: Faculdade de Odontologia de Bauru, Universidade de São Paulo. . Acesso em: 19 jun. 2024. , 2014
APA
Costa, Y. F., Tjioe, K. C., Nonogaki, S., Soares, F. A., Lauris, J. R. P., & Oliveira, D. T. (2014). Is the podoplanin associated with ezrin part of the process of invasion by ameloblastomas? Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. Nova York: Faculdade de Odontologia de Bauru, Universidade de São Paulo.
NLM
Costa YF, Tjioe KC, Nonogaki S, Soares FA, Lauris JRP, Oliveira DT. Is the podoplanin associated with ezrin part of the process of invasion by ameloblastomas? Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2014 ; 117( 2): e214.[citado 2024 jun. 19 ]
Vancouver
Costa YF, Tjioe KC, Nonogaki S, Soares FA, Lauris JRP, Oliveira DT. Is the podoplanin associated with ezrin part of the process of invasion by ameloblastomas? Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2014 ; 117( 2): e214.[citado 2024 jun. 19 ]

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Nome do evento

País de publicação

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada